NASDAQ · CMND
Clearmind Medicine Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for CMND has not been announced yet.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews- RTTNews · Oct 27, 10:44 AM EDTClearmind Advances CMND-100 Into Patient Testing For Alcohol Use Disorder; Stock Down(RTTNews) – Clearmind Medicine Inc. (CMND) announced completion of patient recruitment for the first cohort of Part B of its Phase I/IIa clinical trial evaluating CMND-100 in patients with moderate-to-severe alcohol use disorder (AUD).
- RTTNews · Oct 12, 8:44 AM EDTClearmind Subsidiary Launches Wireless EV-Charging Platform For Autonomous Fleets(RTTNews) – Clearmind Medicine (CMND) announced that its 51%-owned subsidiary, Charging Robotics Ltd., has launched a next-generation automated electric vehicle charging platform designed for robotaxis, autonomous fleets and automated parking facilities.
- RTTNews · Oct 8, 1:51 PM EDTClearmind Gains Japan Patent Coverage For 3-MMC And PEA Combination(RTTNews) – Clearmind Medicine (CMND) announced the publication in Japan of a patent application covering novel compositions and methods for treating dyskinesia, a neurological movement disorder characterized by involuntary movements.
- RTTNews · Oct 7, 10:13 AM EDTClearmind Seeks Streamlined FDA Review For Neuroplastogen Therapies(RTTNews) – Clearmind Medicine Inc. (CMND), a clinical-stage biopharmaceutical company, announced on Wednesday that it has submitted recommendations to the U.S. Food and Drug Administration (FDA) regarding the potential future therapeutic use of psychedelic-derived therapies.
- RTTNews · Sep 26, 12:35 PM EDTClearmind Reports U.S. Patent Applications For Drug Combinations In Mental Health(RTTNews) – Clearmind Medicine Inc. (CMND), a clinical-stage biopharmaceutical company, announced this week the publications of three U.S. patents covering certain proprietary drug combinations to treat a range of mental health disorders. The proprietary, novel combinations co
- RTTNews · Sep 17, 2:28 PM EDTBiotech Stocks In Focus: Aethlon, Tiziana, Capricor, Firefly & Clearmind(RTTNews) – Biotech stocks were in focus Thursday following a series of company updates, including Aethlon Medical's proposed merger with North Immunology, Tiziana Life Sciences' MS trial collaboration, Capricor's upcoming Duchenne data, Firefly Neuroscience's brain-medicine part
- RTTNews · Sep 17, 9:58 AM EDTClearmind Medicine Briefs FDA On Patient Access At Psychedelic Hearing(RTTNews) – Clearmind Medicine Inc. (CMND) announced that its Chief of Global Impact, Mary-Elizabeth Gifford, testified at a U.S. Food and Drug Administration (FDA) hearing on the potential future therapeutic use of psychedelic drugs in Washington, D.C., on September 14, 2026.
- RTTNews · Sep 11, 9:49 AM EDTClearmind Advances CMND-100 With First AUD Patients Enrolled(RTTNews) – Clearmind Medicine Inc. (CMND) announced that the first patients with Alcohol Use Disorder (AUD) have been enrolled in its ongoing clinical trial of CMND-100, the company's proprietary non-hallucinogenic psychedelic-derived treatment candidate.
- RTTNews · Sep 8, 7:52 AM EDTClearmind Medicine Receives Yale IRB Approval For CMND-100 Trial(RTTNews) – Clearmind Medicine Inc. (CMND) announced that the Yale University Institutional Review Board (IRB) approved patient recruitment for Parts B and C of its Phase I/II clinical trial evaluating CMND-100 for alcohol use disorder (AUD).
- RTTNews · Sep 4, 7:49 AM EDTClearmind Medicine To Acquire 51% Stake In Charging Robotics For $2.5 Million(RTTNews) – Biotech company Clearmind Medicine, Inc. (CMND) announced Friday that it has entered into a definitive agreement to acquire a 51% stake in Charging Robotics, an intelligent EV wireless charging solutions provider.
- RTTNews · Sep 1, 9:29 AM EDTClearmind Advances CMND-100 Into Phase 2a Trial For Alcohol Use Disorder; Stock Down(RTTNews) – Clearmind Medicine Inc. (CMND), a clinical-stage biopharmaceutical company, on Tuesday reported the initiation of the Phase 2a study of its Phase 1/2a trial evaluating CMND-100 in Alcohol Use Disorder (AUD).
- RTTNews · Aug 24, 9:30 AM EDTSciSparc Advances MDMA-PEA IP For PTSD As FDA Provides Psychedelic Drug Guidance(RTTNews) – SciSparc Ltd. (SPRC), through its subsidiary NeuroThera Labs Inc., announced that its collaboration with Clearmind Medicine Inc. (CMND) has advanced with the U.S. publication of a patent application covering a novel combination of MDMA and N-acylethanolamines such as
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Clearmind Medicine Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.